<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Ther Drug Monit[TA]</title><link>http://www.unboundmedicine.com/medline/ebm/journal/Ther_Drug_Monit</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Determination of Linezolid in Human Plasma by High-Performance Liquid Chromatography With Ultraviolet Detection.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20300050/full_citation/Determination_of_Linezolid_in_Human_Plasma_by_High_Performance_Liquid_Chromatography_With_Ultraviolet_Detection_</link><description>Cattaneo D, Baldelli S, Conti F, et al. <br/><span class="title">Determination of Linezolid in Human Plasma by High-Performance Liquid Chromatography With Ultraviolet Detection. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20300050/abstract/Determination_of_Linezolid_in_Human_Plasma_by_High_Performance_Liquid_Chromatography_With_Ultraviolet_Detection_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20300050/full_citation/Determination_of_Linezolid_in_Human_Plasma_by_High_Performance_Liquid_Chromatography_With_Ultraviolet_Detection_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20300050/Determination_of_Linezolid_in_Human_Plasma_by_High_Performance_Liquid_Chromatography_With_Ultraviolet_Detection_">Find Related Articles</a> </description></item><item><title>Prediction of Intravenous Cyclosporine Area Under the Concentration-Time Curve After Allogeneic Stem Cell Transplantation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20224513/full_citation/Prediction_of_Intravenous_Cyclosporine_Area_Under_the_Concentration_Time_Curve_After_Allogeneic_Stem_Cell_Transplantation_</link><description>Duncan N, Arrazi J, Nagra S, et al. <br/><span class="title">Prediction of Intravenous Cyclosporine Area Under the Concentration-Time Curve After Allogeneic Stem Cell Transplantation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20224513/abstract/Prediction_of_Intravenous_Cyclosporine_Area_Under_the_Concentration_Time_Curve_After_Allogeneic_Stem_Cell_Transplantation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20224513/full_citation/Prediction_of_Intravenous_Cyclosporine_Area_Under_the_Concentration_Time_Curve_After_Allogeneic_Stem_Cell_Transplantation_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20224513/Prediction_of_Intravenous_Cyclosporine_Area_Under_the_Concentration_Time_Curve_After_Allogeneic_Stem_Cell_Transplantation_">Find Related Articles</a> </description></item><item><title>Trough Infliximab Concentrations Predict Efficacy and Sustained Control of Disease Activity in Rheumatoid Arthritis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20216124/full_citation/Trough_Infliximab_Concentrations_Predict_Efficacy_and_Sustained_Control_of_Disease_Activity_in_Rheumatoid_Arthritis_</link><description>Mulleman D, Lin DC, Ducourau E, et al. <br/><span class="title">Trough Infliximab Concentrations Predict Efficacy and Sustained Control of Disease Activity in Rheumatoid Arthritis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20216124/abstract/Trough_Infliximab_Concentrations_Predict_Efficacy_and_Sustained_Control_of_Disease_Activity_in_Rheumatoid_Arthritis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20216124/full_citation/Trough_Infliximab_Concentrations_Predict_Efficacy_and_Sustained_Control_of_Disease_Activity_in_Rheumatoid_Arthritis_">Full Citation</a></description></item><item><title>Clinical Repercussions of Analytical Interferences Due to Aldosterone Antagonists in Digoxin Immunoassays: An Assessment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20216123/full_citation/Clinical_Repercussions_of_Analytical_Interferences_Due_to_Aldosterone_Antagonists_in_Digoxin_Immunoassays:_An_Assessment_</link><description>Cobo A, Martín-Suarez A, Calvo MV, et al. <br/><span class="title">Clinical Repercussions of Analytical Interferences Due to Aldosterone Antagonists in Digoxin Immunoassays: An Assessment. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20216123/abstract/Clinical_Repercussions_of_Analytical_Interferences_Due_to_Aldosterone_Antagonists_in_Digoxin_Immunoassays:_An_Assessment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20216123/full_citation/Clinical_Repercussions_of_Analytical_Interferences_Due_to_Aldosterone_Antagonists_in_Digoxin_Immunoassays:_An_Assessment_">Full Citation</a></description></item><item><title>UGT2B7_-161C&gt;T Polymorphism Is Associated With Lamotrigine Concentration-to-Dose Ratio in a Multivariate Study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20216122/full_citation/UGT2B7__161C&gt;T_Polymorphism_Is_Associated_With_Lamotrigine_Concentration_to_Dose_Ratio_in_a_Multivariate_Study_</link><description>Blanca Sánchez M, Herranz JL, Leno C, et al. <br/><span class="title">UGT2B7_-161C&gt;T Polymorphism Is Associated With Lamotrigine Concentration-to-Dose Ratio in a Multivariate Study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20216122/abstract/UGT2B7__161C&gt;T_Polymorphism_Is_Associated_With_Lamotrigine_Concentration_to_Dose_Ratio_in_a_Multivariate_Study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20216122/full_citation/UGT2B7__161C&gt;T_Polymorphism_Is_Associated_With_Lamotrigine_Concentration_to_Dose_Ratio_in_a_Multivariate_Study_">Full Citation</a></description></item><item><title>Population Pharmacokinetics of Modafinil in Chinese Han, Mongolian, Korean, Uygur, and Hui Healthy Subjects Determined by Nonlinear Mixed-Effects Modeling.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20216121/full_citation/Population_Pharmacokinetics_of_Modafinil_in_Chinese_Han_Mongolian_Korean_Uygur_and_Hui_Healthy_Subjects_Determined_by_Nonlinear_Mixed_Effects_Modeling_</link><description>Tao G, Longshan Z, Kehua W, et al. <br/><span class="title">Population Pharmacokinetics of Modafinil in Chinese Han, Mongolian, Korean, Uygur, and Hui Healthy Subjects Determined by Nonlinear Mixed-Effects Modeling. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20216121/abstract/Population_Pharmacokinetics_of_Modafinil_in_Chinese_Han_Mongolian_Korean_Uygur_and_Hui_Healthy_Subjects_Determined_by_Nonlinear_Mixed_Effects_Modeling_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20216121/full_citation/Population_Pharmacokinetics_of_Modafinil_in_Chinese_Han_Mongolian_Korean_Uygur_and_Hui_Healthy_Subjects_Determined_by_Nonlinear_Mixed_Effects_Modeling_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0163-4356%26amp;volume=%26amp;issue=%26amp;spage=">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/20216121/Population_Pharmacokinetics_of_Modafinil_in_Chinese_Han_Mongolian_Korean_Uygur_and_Hui_Healthy_Subjects_Determined_by_Nonlinear_Mixed_Effects_Modeling_">Find Related Articles</a> </description></item><item><title>Determination of Saliva Trough Levels for Monitoring Voriconazole Therapy in Immunocompromised Children and Adults.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20216120/full_citation/Determination_of_Saliva_Trough_Levels_for_Monitoring_Voriconazole_Therapy_in_Immunocompromised_Children_and_Adults_</link><description>Michael C, Bierbach U, Frenzel K, et al. <br/><span class="title">Determination of Saliva Trough Levels for Monitoring Voriconazole Therapy in Immunocompromised Children and Adults. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20216120/abstract/Determination_of_Saliva_Trough_Levels_for_Monitoring_Voriconazole_Therapy_in_Immunocompromised_Children_and_Adults_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20216120/full_citation/Determination_of_Saliva_Trough_Levels_for_Monitoring_Voriconazole_Therapy_in_Immunocompromised_Children_and_Adults_">Full Citation</a></description></item><item><title>Maternal Buprenorphine Dose, Placenta Buprenorphine, and Metabolite Concentrations and Neonatal Outcomes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20216119/full_citation/Maternal_Buprenorphine_Dose_Placenta_Buprenorphine_and_Metabolite_Concentrations_and_Neonatal_Outcomes_</link><description>Concheiro M, Jones HE, Johnson RE, et al. <br/><span class="title">Maternal Buprenorphine Dose, Placenta Buprenorphine, and Metabolite Concentrations and Neonatal Outcomes. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20216119/abstract/Maternal_Buprenorphine_Dose_Placenta_Buprenorphine_and_Metabolite_Concentrations_and_Neonatal_Outcomes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20216119/full_citation/Maternal_Buprenorphine_Dose_Placenta_Buprenorphine_and_Metabolite_Concentrations_and_Neonatal_Outcomes_">Full Citation</a></description></item><item><title>Determination of 6-Thioguanosine Diphosphate and Triphosphate and Nucleoside Diphosphate Kinase Activity in Erythrocytes: Novel Targets for Thiopurine Therapy?</title><link>http://www.unboundmedicine.com/medline/ebm/record/20216118/full_citation/Determination_of_6_Thioguanosine_Diphosphate_and_Triphosphate_and_Nucleoside_Diphosphate_Kinase_Activity_in_Erythrocytes:_Novel_Targets_for_Thiopurine_Therapy</link><description>Karner S, Shi S, Fischer C, et al. <br/><span class="title">Determination of 6-Thioguanosine Diphosphate and Triphosphate and Nucleoside Diphosphate Kinase Activity in Erythrocytes: Novel Targets for Thiopurine Therapy? [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20216118/abstract/Determination_of_6_Thioguanosine_Diphosphate_and_Triphosphate_and_Nucleoside_Diphosphate_Kinase_Activity_in_Erythrocytes:_Novel_Targets_for_Thiopurine_Therapy">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20216118/full_citation/Determination_of_6_Thioguanosine_Diphosphate_and_Triphosphate_and_Nucleoside_Diphosphate_Kinase_Activity_in_Erythrocytes:_Novel_Targets_for_Thiopurine_Therapy">Full Citation</a></description></item><item><title>Mycophenolic Acid Exposure in High- and Low-Weight Renal Transplant Patients After Dosing With Mycophenolate Mofetil in the Opticept Trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/20216117/full_citation/Mycophenolic_Acid_Exposure_in_High__and_Low_Weight_Renal_Transplant_Patients_After_Dosing_With_Mycophenolate_Mofetil_in_the_Opticept_Trial_</link><description>Kaplan B, Gaston RS, Meier-Kriesche HU, et al. <br/><span class="title">Mycophenolic Acid Exposure in High- and Low-Weight Renal Transplant Patients After Dosing With Mycophenolate Mofetil in the Opticept Trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2010 Mar 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/20216117/abstract/Mycophenolic_Acid_Exposure_in_High__and_Low_Weight_Renal_Transplant_Patients_After_Dosing_With_Mycophenolate_Mofetil_in_the_Opticept_Trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/20216117/full_citation/Mycophenolic_Acid_Exposure_in_High__and_Low_Weight_Renal_Transplant_Patients_After_Dosing_With_Mycophenolate_Mofetil_in_the_Opticept_Trial_">Full Citation</a></description></item></channel></rss>